Houston Methodist

Projects

Projects per year 2000 2013 2016 2018 2019 2020 2021 2022 2023 2024 2046

• 194 Not started
• 536 Active
• 819 Finished

Projects per year

Search results

• Not started

  Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma

  Abdelrahim, M. (PI), Chang, J. C. (Key Personnel), Heyne, K. (Key Personnel), Niravath, P. A. (Key Personnel), Singh, M. (Key Personnel) & Templeton, S. (Key Personnel)

  Project: Clinical Trial

• HCMR - Novel

  Nagueh, S. (PI)

  Project: Clinical Trial

• Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene autoleucel (cilta-cel) Out-of-Specification (OOS) in patients with Multiple Myeloma

  Ganguly, S. (PI), Mai, H. P. (Key Personnel), Pingali, S. R. (Key Personnel) & Shah, S. (Key Personnel)

  Project: Clinical Trial

• An Open-label Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Tirabrutinib in Patients With Primary Central Nervous System Lymphoma (PCNSL)

  Pingali, S. R. (Key Personnel) & Shah, S. (Key Personnel)

  Project: Clinical Trial

• CardOnc screening

  Bhimaraj, A. (Key Personnel), Guha, A. (Key Personnel), Niravath, P. A. (Key Personnel) & Pingali, S. R. (Key Personnel)

  Project: Clinical Trial

• Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy

  Zhang, J. (PI), Chan, E. Y. (Key Personnel), Gibbs, J. M. (Key Personnel), Heyne, K. (Key Personnel), Kim, M. P. (Key Personnel), Rudkovskaia, A. A. (Key Personnel) & Singh, M. (Key Personnel)

  Project: Clinical Trial

• Randomized Study of Erlotinib vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

  Zhang, J. (PI), Chang, J. C. (Key Personnel), Heyne, K. (Key Personnel), Niravath, P. A. (Key Personnel) & Singh, M. (Key Personnel)

  Project: Clinical Trial

• Katherine, B50, for Treatment of Adjuvant HER2 Positive Breast Cancer

  Chang, J. C. (PI), Niravath, P. A. (Key Personnel) & Singh, M. (Key Personnel)

  Project: Clinical Trial

• A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of K0706 in Subjects With Early Parkinson's Disease

  Ondo, W. G. (PI) & Waln, O. (Key Personnel)

  Project: Clinical Trial

• The Effect of Semaglutide in Subjects with Non-cirrhotic Non-alcoholic Steatohepatitis (NASH)

  Victor, III, D. W. (PI) & Kodali, S. (Key Personnel)

  Project: Clinical Trial

• A Phase 1 Study of SEA-CD70 in Myeloid Malignancies

  Shah, S. (PI), Ganguly, S. (Key Personnel) & Pingali, S. R. (Key Personnel)

  Project: Clinical Trial

• Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer (INTEGRAL)

  Chang, J. C. (PI), Mai, H. P. (Key Personnel), Niravath, P. A. (Key Personnel), Sun, K. (Key Personnel) & Venta, L. A. (Key Personnel)

  Project: Clinical Trial

• BO41843: Phase III_GDC-9545 RO7197597_Breast Cancer_Roche BO41843: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of GDC-9545 Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Patients With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

  Niravath, P. A. (PI), Chang, J. C. (Key Personnel), Mai, H. P. (Key Personnel) & Sun, K. (Key Personnel)

  Project: Clinical Trial

• MRI Scan Volunteers

  Gupta, N. (PI) & Martin, D. R. (Key Personnel)

  Project: Clinical Trial

• SH-PORTICO NG

  Kleiman, N. (PI), Faza, N. (Key Personnel), Goel, S. (Key Personnel), Little, S. H. (Key Personnel) & Reardon, M. J. (Key Personnel)

  Project: Clinical Trial

• AGENTA - Numares -- GFRnmr-HF Study - Accuracy of eGFR in Hospitalized Patients with Heart Failure at Discharge using NMR Analysis

  Bobart, S. A. (PI) & Nasir, K. (Key Personnel)

  Project: Clinical Trial

• Pharmacokinetic Analysis of Once-Daily Everolimus and Extended-Release Tacrolimus in Renal Transplant Recipients (CRAD001AUS214T) (PO#3004249477)

  Gaber, A. O. (PI), Hobeika, M. J. (Key Personnel), Knight, R. J. (Key Personnel), Saharia, A. (Key Personnel) & Yi, S. (Key Personnel)

  Project: Clinical Trial

• ARIA II: A Phase III Randomized Controlled Trial of Near-Infrared Angiography During Rectosigmoid Resection and Anastomosis in Women with Ovarian Cancer.

  Zaid, T. (PI), Alaniz, A. (Key Personnel), Kamat, A. A. (Key Personnel), Ramirez, P. T. (Key Personnel), Snyder, M. J. (Key Personnel) & Suri, A. (Key Personnel)

  Project: Clinical Trial

• An Open-Label, Controlled, Randomized Phase 3 Trial Evaluating 12-Month Kidney Function in Highly Sensitized (cPRA =99.9%) Kidney Transplant Patients with Positive Crossmatch Against a Deceased Donor, Using Imlifidase with Standard of Care

  Gaber, A. O. (PI), Knight, R. J. (Key Personnel) & Yi, S. (Key Personnel)

  Project: Clinical Trial

• A randomized double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease (VICTORION-2 PREVENT)

  Volpi, J. J. (PI), Chang, S.-M. (Key Personnel), Chiu, D. (Key Personnel), Gadhia, R. R. (Key Personnel), Garg, T. (Key Personnel), Hodics, T. M. (Key Personnel) & Misra, V. (Key Personnel)

  Project: Clinical Trial

• NRG-GY018. Also PRO00022968

  Zaid, T. (PI), Alaniz, A. (Key Personnel), Singh, M. (Key Personnel) & Suri, A. (Key Personnel)

  Project: Clinical Trial

• Comparative Proteomic Analysis of Aortic and Iliac Aneurysms

  Rahimi, M. (PI), Fang, L. (Key Personnel), Le, L. (Key Personnel), Lumsden, A. B. (Key Personnel), Peden, E. K. (Key Personnel) & Reardon, M. J. (Key Personnel)

  Project: Clinical Trial

• GOG0286B

  Kamat, A. A. (PI), Alaniz, A. (Key Personnel), Singh, M. (Key Personnel), Suri, A. (Key Personnel) & Zaid, T. (Key Personnel)

  Project: Clinical Trial

• HMDHVC Clinical CMR Database

  Shah, D. J. (PI), El-Tallawi, C. (Key Personnel), Faza, N. (Key Personnel), Graviss, E. A. (Key Personnel), Lin, C. H. (Key Personnel) & Nabi, F. (Key Personnel)

  Project: Clinical Trial

• MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

  Zaid, T. (PI), Alaniz, A. (Key Personnel), Beinart, G. (Key Personnel), Coffey, D. (Key Personnel), Ramirez, P. T. (Key Personnel), Singh, M. (Key Personnel) & Suri, A. (Key Personnel)

  Project: Clinical Trial

• Brain Metastases Registry

  Rostomily, R. C. (PI), Baskin, D. S. (Key Personnel), Bernicker, E. H. (Key Personnel), Britz, G. W. (Key Personnel), Butler, E. B. (Key Personnel), Chang, J. C. (Key Personnel), Farach, A. M. (Key Personnel), Fung, S. H. (Key Personnel) & Teh, B. S. (Key Personnel)

  Project: Clinical Trial

• A Phase 3, Multicenter, Randomized, Controlled, Open-Label, Assessor-Blinded Study to Evaluate the Efficacy and Safety of Inhaled Isoflurane Delivered via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)

  Faisal, H. (PI), Dhala, A. (Key Personnel), Masud, F. N. (Key Personnel), Mobley, C. M. (Key Personnel), Moore, L. W. (Key Personnel), Rizk, E. (Key Personnel) & Sanchez Leon, R. (Key Personnel)

  Project: Clinical Trial

• GOG-0225

  Kamat, A. A. (PI), Alaniz, A. (Key Personnel), Singh, M. (Key Personnel) & Suri, A. (Key Personnel)

  Project: Clinical Trial

• A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo

  Niravath, P. A. (PI), Abdelrahim, M. (Key Personnel), Arentz, C. (Key Personnel), Chang, J. C. (Key Personnel), Heyne, K. (Key Personnel) & Singh, M. (Key Personnel)

  Project: Clinical Trial

• SNAP - Staphylococcus aureus Network Adaptive Platform trial

  Arias, C. A. (PI), Miller, W. R. (Key Personnel) & Tran, C. (Key Personnel)

  Project: Clinical Trial

• Comparison of Diagnostic accuracy of Flurpiridaz and Rubidium PET

  Al-Mallah, M. (PI) & Al Rifai, M. S. (Key Personnel)

  Project: Clinical Trial

• A Phase 1/2 Study of BMS-986340 as Monotherapy and in Combination with Nivolumab in Participants with Advanced Solid Tumors

  Abdelrahim, M. (PI), Heyne, K. (Key Personnel), Singh, M. (Key Personnel), Sun, K. (Key Personnel) & Zhang, J. (Key Personnel)

  Project: Clinical Trial

• IMAG-MyoKardia MYK-461-007

  Nagueh, S. (PI), Chamsi-Pasha, M. A. (Key Personnel), Kurrelmeyer, K. M. (Key Personnel) & Shah, D. J. (Key Personnel)

  Project: Clinical Trial

• A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy

  Templeton, S. (PI), Arentz, C. (Key Personnel), Chang, J. C. (Key Personnel), Darcourt, J. (Key Personnel), Dubrovsky, E. (Key Personnel), Haque, W. M. (Key Personnel), Heyne, K. (Key Personnel), Morgan, P. B. (Key Personnel), Niravath, P. A. (Key Personnel) & Singh, M. (Key Personnel)

  Project: Clinical Trial

• Neoadjuvant Atezolizumab in Patients With Non-Metastatic Resectable High-Risk Cutaneous Melanoma

  Esnaola, N. F. (PI), Allenson, K. C. (Key Personnel), Chen, S.-H. (Key Personnel), Kain, J. J. (Key Personnel) & Mohyuddin, N. G. (Key Personnel)

  Project: Clinical Trial

• Brain Resting State Functional MRI for Pre-Surgical Planning

  Fung, S. H. (PI), Baskin, D. S. (Key Personnel), Karmonik, C. (Key Personnel) & Rostomily, R. C. (Key Personnel)

  Project: Clinical Trial

• Ultrasound Evaluation for Baxter VASCU-GUARD Vascular Patches Post-Endarterectomy and Complications Assessment

  Rahimi, M. (PI) & Garami, Z. (Key Personnel)

  Project: Clinical Trial

• COMPILATIONS OF CLINICAL FINDINGS IN AMYOTROPHIC LATERAL SCLEROSIS

  Appel, S. H. (PI), Greene, E. P. (Key Personnel), Liao, B. (Key Personnel) & Shroff, S. (Key Personnel)

  Project: Clinical Trial

• Higher neural changes in patients taking overactive bladder medications

  Khavari, R. (PI) & High, R. A. (Key Personnel)

  Project: Clinical Trial

• Sample and Data Collection for Hematologic disorders section, Houston Methodist Cancer Center

  Pingali, S. R. (PI), Ganguly, S. (Key Personnel), Heyne, K. (Key Personnel), Hu, C.-C. A. (Key Personnel), Jin, M. M. (Key Personnel), Rice, L. (Key Personnel), Shah, S. (Key Personnel), Yang, J. (Key Personnel), Yi, Q. (Key Personnel) & Zieske, A. W. (Key Personnel)

  Project: Clinical Trial

• A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (ENGOT-0V44 The FIRST)

  Suri, A. (PI), Alaniz, A. (Key Personnel), Singh, M. (Key Personnel) & Zaid, T. (Key Personnel)

  Project: Clinical Trial

• Real-world experience with Tecentriq + Avastin for the treatment of hepatocellular carcinoma (HCC) in the US

  Abdelrahim, M. (PI), Connor, A. A. (Key Personnel), Dacha, S. (Key Personnel), Esmail, A. (Key Personnel), Esnaola, N. F. (Key Personnel), Ghobrial, R. M. (Key Personnel), Graviss, E. A. (Key Personnel), Gupta, N. (Key Personnel), Heyne, K. (Key Personnel), Hobeika, M. J. (Key Personnel), Kloc, M. (Key Personnel), Kodali, S. (Key Personnel), Mobley, C. M. (Key Personnel), Moore, L. W. (Key Personnel), Noureddin, M. (Key Personnel), Rizk, E. (Key Personnel), Victor, III, D. W. (Key Personnel) & Xu, S. (Key Personnel)

  Project: Clinical Trial

• SH-Low Risk Bicuspid

  Kleiman, N. (PI), Faza, N. (Key Personnel), Goel, S. (Key Personnel), Little, S. H. (Key Personnel), Nabi, F. (Key Personnel) & Reardon, M. J. (Key Personnel)

  Project: Clinical Trial

• Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol (ADNI3)

  Masdeu, J. C. (PI), Nakawah, M. O. (Key Personnel) & Pascual, B. (Key Personnel)

  Project: Clinical Trial